Skip to main content

Table 2 Clinical characteristics and outcome after triple antibiotic therapy

From: Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients

Patient

Age yrs

Duration of symptoms (years)

Previous AB therapy

Blastocystisload in baseline faeces

BlastocystisST’s

SerumIgA g/L

Diary score

Clinical score?>?=1 point

Clearance at 6 weeks

1

35

4

Yes (F,O)

2+

3,4,6

1.51

+4.1

Yes

Yes

2

59

5

No

2+

7

1.12 (L)

+2.4

Yes

No

3

28

1.5

Yes (F)

1+

1

2.1

?0.3

No

No

4

35

0.25

Yes (F,O)

1+

3

2.2

+0.2

No

Yes

5

51

1.5

Yes (F)

1+

3,4,6

2.82

+2.0

Yes

No

6

58

0.5

No

2+

1,4

1.03 (L)

+1.1

Yes

Yes

7

73

0.75

No

1+

3,4

1.22

+4.5

Yes

Yes

8

49

10

Yes (F,O)

3+

8

1.94

+1.3

Yes

No

9

63

1

No

1+

3

0.75 (L)

?0.8

No

Yes

10

36

1

Yes (F)

2+

3

0.98 (L)

?0.6

No

Yes

  1. F = Flagyl.
  2. O = other antibiotics (metronidazole, nitazoxanide, norfloxacillin).
  3. L = low, <1.24 g/L, level defined by laboratory.